Publikationen, an denen er mitarbeitet Daniel Beiroa Tarrío (25)

2024

  1. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

    Molecular Metabolism, Vol. 79

2022

  1. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  2. LEAP-2 Counteracts Ghrelin-Induced Food Intake in a NutrientGrowth Hormone and Age Independent Manner

    Cells, Vol. 11, Núm. 3

  3. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. O-GlcNAcylated p53 in the liver modulates hepatic glucose production

    Nature Communications, Vol. 12, Núm. 1

  2. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner

    Redox Biology, Vol. 41

  3. The L-α-Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis

    Hepatology, Vol. 73, Núm. 2, pp. 606-624

2020

  1. Oral Pharmacological Activation of Hypothalamic Guanylate Cyclase 2C Receptor Stimulates Brown Fat Thermogenesis to Reduce Body Weight

    Neuroendocrinology, Vol. 110, Núm. 11-12, pp. 1042-1053

  2. Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Hypothalamic dopamine signalling regulates brown fat thermogenesis

    Nature Metabolism, Vol. 1, Núm. 8, pp. 811-829

  2. MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance

    Diabetes, Vol. 68, Núm. 12, pp. 2210-2222

  3. Uroguanylin improves leptin responsiveness in diet-induced obese mice

    Nutrients, Vol. 11, Núm. 4

2018

  1. Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis

    Molecular Metabolism, Vol. 8, pp. 132-143

  2. SF1-specific AMPKa1 deletion protects against diet-induced obesity

    Diabetes, Vol. 67, Núm. 11, pp. 2213-2226

  3. SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression

    Nature Communications, Vol. 9, Núm. 1

  4. Sex-Biased Physiological Roles of NPFF1R, the Canonical Receptor of RFRP-3, in Food Intake and Metabolic Homeostasis Revealed by its Congenital Ablation in mice

    Metabolism: Clinical and Experimental, Vol. 87, pp. 87-97

  5. p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1

    Nature Communications, Vol. 9, Núm. 1

2016

  1. Acute stimulation of brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation

    Neuropharmacology, Vol. 110, pp. 322-332

  2. Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators

    BioFactors, Vol. 42, Núm. 6, pp. 600-611

  3. Uroguanylin action in the brain reduces weight gain in obese mice via different efferent autonomic pathways

    Diabetes, Vol. 65, Núm. 2, pp. 421-432